News

Governor Glenn Youngkin Announces Over $3.7 Million in Growth and Opportunity for Virginia Grants

Governor Glenn Youngkin announced today more than $3.7 million in Growth and Opportunity for Virginia (GO Virginia) grant awards for 11 projects designed to empower workforce development, bolster startup ecosystems and promote economic growth in the Commonwealth. These initiatives will play a pivotal role in nurturing skilled talent, fostering entrepreneurial ventures and bridging the gap between job seekers and employment opportunities.

“Today’s announcement underscores our unwavering commitment to stimulating economic growth and expanding opportunities across our Commonwealth,” said Governor Glenn Youngkin. “By investing in talent, bolstering entrepreneurial innovation and cultivating the conditions for startup success, we are actively shaping the future of our workforce and positioning Virginia as a hub for innovation and opportunity.”

The GO Virginia program advances regional economic growth and diversification by enabling cooperative projects that taps into workforce enhancement, cluster expansion, innovative business initiatives and site development.

“The GO Virginia program is at the forefront of driving regional economic growth and diversification by fostering collaborative projects that harness the potential of workforce development and startup ecosystems,” said Secretary of Commerce and Trade Caren Merrick.

In addition to the awarded GO Virginia funding, the 11 awarded projects will leverage an additional $2.5 million in local and non-state funding.

“Congratulations to the regional councils and the awardees. GO Virginia is committed to the economic success of every region of the Commonwealth, and these projects demonstrate how focused strategy and regional collaboration create an ecosystem where industries, communities and individuals can thrive,” said chair of the GO Virginia State Board Nancy Howell Agee.

Since the program’s inception in 2017, GO Virginia has funded 277 projects and awarded approximately $114 million to support regional economic development efforts.

To learn more about the GO Virginia program, visit dhcd.virginia.gov/gova.

A FULL LIST OF THE AWARDED PROJECTS CAN BE FOUND HERE.

Recent News

06/02/2026

TearSolutions Receives FDA Orphan Drug and Fast Track Designations for Lacripep® in Neurotrophic Keratitis and Initiates Phase 2 Clinical Trial with First Patients Dosed

TearSolutions, Inc. (“TearSolutions”), a clinical-stage biotechnology company developing novel ophthalmic therapeutics, today announced receiving Food and Drug Administration (FDA) Orphan Drug (ODD) and Fast Track Designations for Lacripep in Neurotrophic Keratitis (NK) and initiating a Phase 2 clinical trial with first patients dosed. The FDA’s ODD provides incentives, including tax credits for clinical testing and

06/02/2026

Contraline Announces $92.5 Million Series B Financing to Advance NES/T Male Contraceptive into Late-Stage Development

Contraline, Inc., a clinical-stage biopharmaceutical company developing novel male contraceptives, today announced the closing of a $92.5 million Series B financing co-led by BVF Partners L.P. and RA Capital Management, with participation from GV (Google Ventures), Lumira Ventures, Invus, and other new and existing investors. In conjunction with the closing of the Series B financing,

06/02/2026

GEN Names BioHealth Capital Region a Top 3 U.S. Biopharma Cluster for Fourth Year in a Row

The BioHealth Capital Region, spanning Maryland, Virginia, and Washington, D.C., has once again been named one of the nation’s Top 3 biopharma clusters by Genetic Engineering & Biotechnology News (GEN), marking the region’s fourth consecutive year in the Top 3. GEN’s 2026 “Top 10 U.S. Biopharma Clusters” ranking was authored by Alex Philippidis, Senior Business